胎心入室试验联合人工破膜预测分娩及胎儿结局效果评价  

Effect evaluation of admission test combined with artificial rupture of membrane to predict delivery and fetal outcome

作　　者：陈殿红[1] 陈秀俊[1] 刘淑青[1] 滕玲玲[1] 

机构地区：[1]山东省聊城市第二人民医院,252601

出　　处：《中国实用护理杂志（中旬版）》2008年第10期10-13,共4页Chinese Journal of Practical Nursing

基　　金：聊城市科技局科研立项项目（200706350026）

摘　　要：目的探讨胎心入室试验（AT）联合人工破膜对预测胎儿宫内窘迫的价值。方法将2006年5-11月入院后24h内分娩的658例孕妇（33^＋5～43孕周）根据胎心入室试验分为低风险组598例和高风险组60例，分析其胎心入室试验、分娩结局、羊水及新生儿Apgar评分。结果AT示515例为反应型占78．27％，72例为可疑型占10．94％，71例为危险型占10．79％；总的新生儿窒息率为6．53％，反应型窒息率为1．94％，危险型为33．08％；羊水污染率反应型为20．97％，危险型为67．61％，差异有统计学意义（P〈0．01）。高风险组孕妇可疑型、危险型的羊水污染率及新生儿窒息率均较低风险组孕妇高，2组比较差异有统计学意义（P〈0．05）。结论AT反应型可预测在以后的4～5h胎儿在宫内是安全的，胎心入室试验联合人工破膜可预测胎儿预后。Objective To evaluate the value of admission test of fetal heart rate and artificial rupture of membrane in predicting fetal distress in labor. Methods 658 pregnant women who had been pregnant for 33^＋5 to 43 weeks and delivered spontaneously in 24 hours were divided into low risk group（598 cases） and hign risk group（60 cases） according to their admission test. The admission test, result of delivery, amniotic fluid contamination and Apgar scores of newborns were analyzed. Results 515 cases were reactive type（78.27%）, 72 cases were equivocal type（10.94%） and 71 cases were ominous type（10.79% ）. Total incidence of neonatal asphyxia were 6.53%,and it was 1.94% and 33.08% in reactive type subjects and ominous type subjects, respectively. The rates of amniotic fluid contamination were 20. 97% and 67.61% in reactive type subjects and ominous type subjects （P 〈 0.01 ）. The incidence of reactive type and equivocal type of amniotic fluid contamination and neonatal asphyxia were significantly lower in the low risk group than those in the high-risk group （P 〈 0.05 ）. Conclusions Reactive type of admission test can ensure safety of fetus during the subsequent four to five hours. Admission test of fetal heart rate and artificial rupture of membrane can be used to predict fetal outcome in labor.

关 键 词：入室试验 胎儿监测 胎儿窘迫 分娩 人工破膜 

分 类 号：R715.707[医药卫生—妇产科学] R714[医药卫生—临床医学]